Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Registration - In-house Corporation

Baxter Corporation / Stephen Thompson, President & General Manager

Registration Information

In-house Corporation name: Baxter Corporation
Responsible Officer Name: Stephen Thompson, President & General Manager 
Responsible Officer Change History
Initial registration start date: 2007-01-31
Registration status: Inactive
Registration Number: 930614-14650

Associated Communications

Total Number of Communication Reports: 17

Monthly communication reports in the last 6 months: 0

Version 2 of 22 (2007-08-03 to 2008-02-15)

Version 2 of 22 (2007-08-03 to 2008-02-15) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Information about Responsible Officer and Corporation

Corporation: Baxter Corporation
4 Robert Speck Parkway, Ste. 700
Mississauga, ON  L4Z 3Y4
Canada
Telephone number: 905-281-6828
Fax number: 905-281-6570  
Responsible officer name and position during the period of this registration: Barbara Leavitt, President  
Description of activities: Baxter Corporation is the Canadian subsidiary of Baxter International, a global health care company. Baxter's BioScience, Medication Delivery and Renal products and services are used to treat Canadians with such medical conditions as cancer, hemophilia, immune deficiencies, infectious diseases, kidney disease and trauma.
 
The client is a subsidiary of the following parent companies: Baxter International
One Baxter Parkway
Deerfield, IL
United States of America 60015-4625

Coalition The corporation is not a member of a coalition.
Subsidiary: The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking.
Other direct interests The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbyists Employed by the Corporation

Name: Lisa Armour
Position title: Director, Regulatory Affairs
Public offices held: No
 
Name: Pam Bobbette
Position title: VP, Quality Assurance
Public offices held: No
 
Name: Michael Hamilton
Position title: VP, Health Systems and Channel Mgmt
Public offices held: No
 
Name: Barb Leavitt
Position title: President
Public offices held: No
 
Name: Saurabh Popat
Position title: Director Government Affairs & Public Policy
Public offices held: No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Environment Canada, Finance Canada (FIN), Health Canada (HC), Industry Canada, National Defence (DND)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Consumer Issues, Defence, Environment, Finance, Government Procurement, Health, Industry, Science and Technology
 
Subject Matter: Retrospective: Medical equipment funding; pandemic border issues;
Subject Matter: Prospective: Pandemic border issues; regulatory approval times; gmp revisions
 

Details Regarding the Identified Subject Matter

Categories Description
Policy or Program, Bill or Resolution, Legislative Proposal Climate Change
Bill or Resolution, Policy or Program, Legislative Proposal Federal Chemicals Management Plan
Regulation Good Manufacturing Practices (GMP) 2007 Proposed Guidelines
Legislative Proposal, Bill or Resolution, Policy or Program Health Canada regulations & policies (e.g., cost recovery, Therapeutic Products Directorate (TPD), Medical devices bureau).
Bill or Resolution, Legislative Proposal, Policy or Program Patented Medicines Prices Review Board (PMPRB)
Legislative Proposal, Bill or Resolution, Policy or Program Public Health



Responsible Officer Name

This is the responsible officer name as provided in the most recent registration for the corporation or organization.

Name Change History:

Baxter Corporation

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name From To
Baxter Corporation 2010-03-09 2020-11-17

The following names have been used before July 2, 2008

  • Baxter Corporation

Responsible Officer Change History

Baxter Corporation

Responsible Officer History
Responsible Officer Name From (YYYY-MM-DD) To (YYYY-MM-DD)
Stephen Thompson 2017-02-06 2020-11-17
Mike Oliver 2011-10-03 2015-11-02
Barbara Leavitt 2007-01-31 2011-10-03

All Monthly Communication Reports for Baxter Corporation

Stephen Thompson, President & General Manager (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-17 of 17

  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Frank Baylis, MP for Pierrefonds- Dollar | House of Commons
    • Sheryl Groeneweg, Director General | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, Economic Development
    Communication date: 2019-02-07
    Posted date: 2019-02-09
    Communication number: 14650-444762 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nancy Faraday-Smith, Manager | Lifescience Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Investment and Innovation | Innovation, Science and Economic Development Canada (ISED)
    • Marcy Grossman, Executive Director | Invest Canada | Global Affairs Canada (GAC)
    • Elder Marques, Senior advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: International Trade, Science and Technology, Budget, Economic Development
    Communication date: 2018-02-13
    Posted date: 2018-03-02
    Communication number: 14650-420769 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Corinne Guenette, Director, Lifescience Industries | Manufacturing and Lifesciences branch | Innovation, Science and Economic Development Canada (ISED)
    • Chantal Glass, Trade Commissionner LifeScience & Health IT | Consulate General of Canada in Chicago | Global Affairs Canada (GAC)
    • Marcy Grossman, Executive Director | Branding & Marketing | Global Affairs Canada (GAC)
    • Louise Rousseau, Deputy Director | Investor Services Division | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, International Trade, Economic Development
    Communication date: 2017-11-27
    Posted date: 2017-12-01
    Communication number: 14650-414542 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Corinne Guenette, Director | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    • Louise Rousseau, Deputy Director | Investment and Innovation | Global Affairs Canada (GAC)
    • Marcy Grossman, Executive Director | International Business Development- Investment and Innovation | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Economic Development, Employment and Training
    Communication date: 2017-09-28
    Posted date: 2017-10-16
    Communication number: 14650-410221 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament for Mississauga- Streetville | House of Commons

    Subject Matter of the communication: Health, Budget, Labour
    Communication date: 2017-04-04
    Posted date: 2017-04-07
    Communication number: 14650-398036 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Brian Kaufmann, Sr Policy Advisor | Health Canada (HC)

    Subject Matter of the communication: Health, Aboriginal Affairs
    Communication date: 2017-03-29
    Posted date: 2017-04-07
    Communication number: 14650-398035 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rhona Ambrose, Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2014-06-03
    Posted date: 2014-06-30
    Communication number: 14650-329070 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kelvin Kenneth Ogilvie, Senator (N.S.) | Senate of Canada

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2011-09-22
    Posted date: 2011-10-19
    Communication number: 14650-190397 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eve Adams, MP, Mississauga-Brampton South | House of Commons

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2011-09-21
    Posted date: 2011-10-19
    Communication number: 14650-190396 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Phil Harwood, Policy Advisor, Prime Minister's Office | Prime Minister's Office (PMO)

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2011-09-20
    Posted date: 2011-10-19
    Communication number: 14650-190395 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Patrick McIntyre, Director of Policy, Office of the Minister of State (Science & Technology) | Federal Economic Development Agency for Southern Ontario (FedDev)

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2011-09-20
    Posted date: 2011-10-19
    Communication number: 14650-190391 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sean O'Leary, Policy Advisor, Office of the Minister of Industry | Industry Canada

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2011-09-20
    Posted date: 2011-10-19
    Communication number: 14650-190389 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Regan Watts, Director of Strategic Planning, Office of the Minister of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2011-09-20
    Posted date: 2011-10-19
    Communication number: 14650-190387 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kellie Leitch, MP, Simcoe-Grey | House of Commons

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2011-09-20
    Posted date: 2011-10-19
    Communication number: 14650-190386 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rick Dykstra, MP, St. Catherine's | House of Commons

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2011-09-20
    Posted date: 2011-10-19
    Communication number: 14650-190385 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Adler, MP, York Centre | House of Commons

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2011-09-20
    Posted date: 2011-10-19
    Communication number: 14650-190384 View associated registration
  • Baxter Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • James Flaherty, Minister of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry
    Communication date: 2010-08-13
    Posted date: 2010-09-20
    Communication number: 14650-155106 View associated registration

Public offices held:


Date Modified: